GlassScriptPhysician profile
Eric C Klawiter
NPI 1982874046
$40,623.50
in general payments reported to CMS, 2019-2025
14 companies · $14K in 2025
The $14K reported for 2025 was more than what 91% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $116 · 2020: $19.42 · 2021: $11K · 2022: $92.15 · 2023: $12K · 2024: $3,200 · 2025: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $25K · Travel and Lodging: $3,761 · Food and Beverage: $831.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $25,155.00 |
| Travel and Lodging | $3,761.48 |
| Food and Beverage | $831.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $12,707.42 | 2021-2025 | |
| Tg Therapeutics, INC. | $9,242.57 | 2021-2023 | Briumvi |
| Genzyme Corporation | $6,940.76 | 2025 | |
| Emd Serono, INC. | $4,787.18 | 2023 | Evobrutinib |
| Ucb Sa | $3,200.00 | 2024 | |
| Greenwich Biosciences, INC. | $2,618.00 | 2021 | |
| Banner Life Sciences, LLC | $900.00 | 2021 | |
| Alexion Pharmaceuticals, INC. | $116.00 | 2019 | |
| Horizon Therapeutics Plc | $92.15 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $19.42 | 2020 |
4 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Klawiter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.